“…Several pharmacological and molecular studies (Hanft and Gross, 1989;Minneman et al, 1988;Morrow and Creese, 1986;Piascik et al, 1990;Terman et al, 1990;Wilson and Minneman, 1989) have shown that al-adrenoceptors could be subdivided into three different subtypes, a1 A, a1 B, and a1 C, which could possibly use different biochemical mechanisms for signal transduction (Han et al, 1987a,b;Johnson and Minneman, 1987;Morrow and Creese, 1986). Moreover, it has been proposed recently that Prazosin could be considered at high concentration as a selective antagonist for a2adrenoceptors and particularly for a 2 B and a 2 C subtypes which have very similar but distinct pharmacological profiles (Harrison et al, 1991;Akers et al, 1991).…”